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Objective: Inadequate infrainguinal runoff is considered an important risk factor for iliac stent failure. However,
the influence of concomitant infrainguinal arterial reconstruction (CIAR) on iliac stent patency is unknown. This
study evaluated the influence of CIAR on outcome of iliac angioplasty and stenting (IAS) in patients with poor distal
runoff.
Methods: Over 5 years (1996 to 2001), 68 IAS procedures (78 stents) were performed in 62 patients with poor distal
runoff (angiographic runoff score >5). The SVS/AAVS reporting standards were followed to define outcome variables
and risk factors. Data were analyzed with both univariate analysis (Kaplan-Meier method [K-M]) and regression analysis
(Cox proportional hazards model).
Results: Indications for iliac artery stenting were disabling claudication (59%) and limb salvage (41%). Of the 68
procedures, IAS with CIAR was performed in 31 patients (46%), and IAS alone was performed in 37 patients (54%).
Patients undergoing IAS with CIAR were older (P  .03) and had more extensive and multifocal iliac artery occlusive
disease, with more TASC (TransAtlantic Inter-Society Consensus) type C lesions (P  .03), compared with patients
undergoing IAS alone. No other significant differences in risk factors were noted. Runoff scores between patients
undergoing IAS with CIAR and those undergoing IAS alone were not significantly different (median runoff scores, 6
[range, 5-8] and 7 [range, 5-9], respectively; P .77). Primary stent patency rate at 1, 3, and 5 years was 87%, 54%, and
42%, respectively, for patients undergoing IAS with CIAR, and was 76%, 66%, and 55%, respectively, for patients
undergoing IAS. Univariate analysis revealed that primary stent patency rate was not significantly different between the
2 groups (K-M, log-rank test, P .81). Primary graft patency rate for CIAR was 81%, 52%, and 46% at 1, 3, and 5 years,
respectively. Performing CIAR did not affect primary iliac stent patency (relative risk, 1.1; 95% confidence interval,
0.49-2.47; P  .81). Overall, there was a trend toward improved limb salvage in patients undergoing IAS with CIAR,
compared with those undergoing IAS alone (K-M, log rank test, P  .07).
Conclusion: In patients undergoing IAS with poor distal runoff, CIAR does not improve iliac artery stent patency.
Infrainguinal bypass procedures should therefore be reserved for patients who do not demonstrate clinical improvement
and possibly for those with limb-threatening ischemia. (J Vasc Surg 2003;38:479-85.)
Iliac angioplasty and stenting (IAS) is an established
option for treatment of iliac artery occlusive disease.1-4
However, risk factors for primary iliac artery stent failure
have been identified, and include female sex, poor run-
off, and presence of external iliac artery lesions.1,3-5 In
theory, poor runoff could be improved with concomitant
infrainguinal arterial reconstruction (CIAR) that by-
passes the infrainguinal lesions that account for the
adverse outflow, but this has not been proved. Although
IAS with CIAR has been used more recently for arterial
reconstructions in patients with multisegmental arterial
occlusive disease, the outcome of these combined pro-
cedures is not well known.6-11 Furthermore, performing
CIAR is not always justified in patients with iliac and
infrainguinal arterial occlusive disease, because in most
of these patients only intervention to treat aortoiliac
lesions is required.12
This study was designed to assess the need and
efficacy of CIAR in patients undergoing IAS to treat
iliac artery occlusive disease associated with poor
infrainguinal runoff. The most current recommenda-
tions and standards were used to define the different
variables.13-15
METHODS
Among 394 IAS procedures performed from July 1996
to December 2001, 68 (78 stents) were performed in 62
patients with iliac artery lesions associated with poor distal
runoff. Runoff was determined from preoperative and in-
traoperative arteriograms, according to the criteria pre-
pared and revised by the Ad Hoc Committee on Reporting
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Standards of the Society for Vascular Surgery and the
American Association for Vascular Surgery (SVS/
AAVS).13,15 Only patients with iliac artery lesions in whom
runoff score at angiography was 5 or higher were included
in the study. Infrainguinal bypass grafting performed
within 30 days of iliac stent placement was considered a
concomitant procedure intended to improve distal runoff.
Patients undergoing infrainguinal arterial reconstruction
after 30 days or before IAS were not included. Likewise,
patients undergoing IAS combined with infrainguinal
endovascular procedures and those undergoing iliac angio-
plasty alone with CIAR were excluded. All patients had
evidence of chronic limb ischemia and were included in a
retrospective cohort study. Preoperative, intraoperative,
and follow-up information was available for all patients,
and was obtained via office and hospital chart review,
dictated operative records, and telephone conversations
with patients, family members, or physicians. The study
protocol was approved by the local institutional review
board.
Endovascular procedures were performed in the op-
erating room by vascular surgeons. Arteriography was
performed through an ipsilateral or contralateral femoral
approach. Primary or selective stent placement was
performed at the discretion of the physician performing
the procedure. Patients underwent primary stenting
when stents were deployed as the primary method of
treatment of iliac lesions rather than for treatment of
suboptimal results after iliac angioplasty alone (selective
stenting). Balloon-expandable stents (Palmaz or Palmaz
Genesis stents, Cordis J and J, Warren, NJ; and AVE
Bridge stents, Medtronic/AVE, Santa Rosa, Calif)
were used preferentially to treat focal lesions, severely
calcified lesions, and all lesions adjacent to the aortic
bifurcation. Self-expandable stents (Wallstent, Boston
Scientific Vascular, Natick, Mass; Cordis SMART Stents,
Cordis J and J; or Bridge SE stents, Medtronic/AVE)
were usually placed in patients with long-segment dis-
ease or tortuous iliac arteries and for contralateral ap-
proaches. Pressure gradient was determined, primarily to
evaluate moderate (30%-50%) stenosis and residual mod-
erate and severe (30%) stenosis, and to document
hemodynamic improvement of these lesions. Stent place-
ment was deemed technically successful if there was less
than 30% residual stenosis and the gradient across the
treated lesion was less than 5 mm Hg. The decision to
perform CIAR was at the discretion of each responsible
surgeon.
Iliac artery stent and infrainguinal artery bypass graft
patency rates were determined with the SVS/AAVS crite-
ria.15 Primary patency was defined as a patent stent or graft
without recurrent stenosis or need for further intervention.
There was no strict postoperative surveillance protocol.
However, patients were usually seen within 2 weeks after
the procedure. Improvement and changes in clinical status
were determined with history and noninvasive vascular
laboratory tests. Postoperative follow-up (clinical and serial
duplex ultrasound scanning examinations) was conducted
every 3 months during the first postoperative year and every
6 months thereafter. Arteriography was performed when
noninvasive arterial testing revealed a decrease in ankle-
brachial index of 0.15 or more or if duplex scanning
peak systolic velocity ratio across the treated lesion was
greater than 2.5. Indications for repeat intervention
included stenosis greater than 60% and gradient across
the lesion greater than 15 mm Hg with papaverine or
greater than 10 mm Hg at rest. All revisions performed
based on these criteria or occlusion were considered
stent failure and the end of primary patency.15 Survival
could be established by telephone contact, but patency
and limb salvage were determined at the most recent
examination.
All analyses were performed according to intention
to treat, that is, including initial technical failures. Contin-
uous variables were expressed as median and range, and
were analyzed with the Mann-Whitney U test for unpaired
comparisons. Exact P values are given, and P  .05 is
considered significant. Univariate analysis of categorical
variables was performed with the 2 test (2 for inde-
pendent groups, two-tailed P value) or Fisher exact test, as
appropriate. Primary patency, limb salvage, and patient
survival were determined with the Kaplan-Meier method
(K-M), and differences with the log-rank test.16 Cox
proportional hazards model with time-dependent covariate
was used for regression analysis, to assess the influence
of various risk factors on primary patency, limb salvage,
and patient survival.17 Variables with P value less than .25
at univariate analysis and those known to be important
or possible confounding factors were entered into the
regression model and considered significant by forward
stepwise selection if P was less than .05 in the final
regression equation. The relative risk (RR) and 95%
confidence interval (95% CI) for the different variables
were estimated with this method.17 For statistical analyses,
SPSS for Windows (version 10.0; SPSS Inc, Chicago, Ill)
was used.
RESULTS
Patients and procedures. Patient median age was 64
years (range, 42-83 years). The most commonly associated
risk factors were history of smoking (80%), hypertension
(79%), coronary artery disease (74%), hyperlipidemia
(64%), and diabetes mellitus (43%). Indications for revas-
cularization were disabling claudication in 40 procedures
(59%) and limb salvage in 28 procedures (41%; ischemic
rest pain in 8 [12%], tissue loss in 20 [29%]). Median
preoperative ankle-brachial index at rest was 0.54 (range,
0-0.88). Median follow-up was 34 months (range, 3-60
months).
Iliac stents were placed primarily in 24 procedures
(36%), and selective stenting was performed because of
significant residual stenosis or pressure gradient after
angioplasty (55%) and dissection after balloon angio-
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plasty (9%). Balloon-expandable stents were used in 32
procedures (46%), self-expanding stents in 34 proce-
dures (50%), and a combination of both stents in 2
procedures (4%). Stents were placed in 5 (7%) TransAt-
lantic Inter-Society Consensus (TASC) type A iliac le-
sions, 27 (40%) type B lesions, 30 (44%) type C lesions,
and 6 (9%) type D lesions. Twenty-nine (43%) stent
placement procedures were performed to treat common
iliac artery lesions, 10 (15%) to treat external iliac artery
lesions, and 29 (43%) to treat lesions in both arteries.
Initial technical success was obtained in 66 procedures
(97%). CIAR was performed in 31 patients (46%). Twen-
ty-five CIARs (37%) were performed at the same opera-
tive setting as IAS. Autogenous vein was used in 20
CIARs (65%), polytetrafluoroethylene graft in 9 (29%),
and polytetrafluoroethylene-vein composite grafts in 2
(6%). Nine CIARs were femoral to above-knee popliteal
(29%), 15 were femoral to below-knee popliteal (48%),
and 7 were femorotibial (23%). The common femoral
artery was the inflow artery in all patients.
Univariate analyses revealed that patients undergoing
IAS with CIAR were older than those undergoing IAS
alone (median age, 69 and 57 years, respectively; P .03),
but no other significant differences in comorbidity were
noted (Table I). Iliac artery occlusive disease was more
extensive and multifocal in the group with IAS with CIAR,
with more TASC type C lesions than in the group with IAS
alone (61% vs 30%; 2 test, P  .03; Table II). Of impor-
Table II. Distribution, characteristics and procedural factors of 68 iliac angioplasty and stenting procedures comparing
IAS with CIAR group and IAS alone group
IAS with CIAR group (%)
(n  31)
IAS alone group (%)
(n  37) P value
Angiographic runoff score (median) 6 (5-8) 7 (5-9) .77*
Iliac occlusion 2 (6) 3 (8) 1.00
TASC stratification of iliac lesions
Type A 2 (6) 5 (14) .44
Type B 9 (29) 20 (54) .06†
Type C 19 (61) 11 (30) .03†
Type D 1 (3) 1 (3) 1.00
Primary stent placement 9 (29) 12 (32) .97
Stent type
Balloon-expandable 11 (35) 21 (57) .13
Self-expanding 19 (61) 15 (41) .14
Both 1 (3) 1 (3) 1.00
Superficial femoral artery
Stenosis 14 (45) 13 (35) .55
Occlusion 17 (55) 24 (65) .55
Tibial artery patency
3 vessel 7 (23) 6 (16) .72
2 vessel 17 (55) 19 (51) .96
1 vessel 7 (23) 12 (32) .53
IAS, Iliac angioplasty and stenting; CIAR, concomitant infrainguinal arterial reconstruction; TASC, Trans Atlantic Inter-Society Consensus.
* Mann-Whitney U test.
† 2 analysis.
Table I. Clinical characteristics of patient groups: IAS with CIAR group and IAS alone group
IAS with CIAR group (%)
(n  27)
IAS alone group (%)
(n  35) P value
Median age 69 57 .03*
Female sex 9 (33) 13 (38) .96
Limb-threatening ischemia 15 (56) 11 (31) .09†
Comorbidities
Diabetes mellitus 10 (36) 17 (48) .52
Hypertension 23 (81) 26 (74) .46
Tobacco abuse 22 (71) 32 (83) .28
Coronary artery disease 23 (81) 28 (80) .74
Hyperlipidemia 19 (71) 22 (63) .26
IAS, Iliac angioplasty and stenting; CIAR, concomitant infrainguinal arterial reconstruction.
* Mann-Whitney U test.
† 2 analysis.
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tance, runoff scores were not significantly different between
the two groups; median runoff score for patients undergo-
ing iliac artery angioplasty and stenting with concomitant
infrainguinal arterial reconstruction was 6 (range, 5-8), and
for patients undergoing iliac artery angioplasty and stenting
alone was 7 (range, 5-9).
Initial results. Initial technical success was obtained
in 66 iliac endovascular procedures (97%). Hemodynamic
success and clinical improvement, as defined by the SVS/
AAVS reporting standards, was obtained in 95% of pa-
tients.15 Forty-six percent of patients demonstrated clinical
improvement to category 3, 39% to category 2, and
10% to category 1. In 1% of patients clinical status was
unchanged, and was worse in 3%: category 1, 1%; category
2, 1%; category 3, 1%. Local complications included super-
ficial wound infection in 5 patients (7%) and deep infection
that required drainage in 1 patient (1%). No graft or stent
infection occurred. One operative (30-day) death occurred
after myocardial infarction in a patient who underwent IAS
with CIAR.
Long-term results. Cumulative primary stent pa-
tency rate for all IAS procedures at 1, 3, and 5 years was
84%, 59%, and 48%, respectively. Patients undergoing
IAS with CIAR did not have significantly different pri-
mary stent patency compared with those undergoing IAS
alone, at univariate analysis (K-M, log-rank test, P .81)
(Figure). Primary stent patency rates at 1, 3, and 5 years
were 87%, 54%, and 42%, respectively, in patients under-
going IAS with CIAR, and 76%, 66%, and 55%, respec-
tively, in patients undergoing IAS alone. When initial
technical failures were excluded, 5-year primary patency
rate was 42% after IAS with CIAR and 58% after IAS
alone, which was not statistically different at survival
analysis (K-M, log-rank test, P  .52). Univariate anal-
ysis revealed a trend in women and smokers toward
decreased primary stent patency (K-M, log-rank test, P
.06), whereas primary stent patency rate was not signif-
icantly different with respect to other risk factors. Re-
gression analysis did not reveal any independent predic-
tors for decreased primary stent patency. CIAR did not
affect primary iliac stent patency (RR, 1.1; 95% CI,
0.49-2.47; P  .81). Stratified analysis adjusted for
grade of ischemia was limited by insufficient number of
patients in the various subgroups. In patients with criti-
cal ischemia, however, there was a trend for higher iliac
stent patency after IAS with CIAR compared with IAS
alone (3-year primary stent patency rate, 83% and 56%,
respectively; K-M, log rank test, P .16). This trend was
not observed in patients with disabling claudication.
Primary iliac artery stent patency rate was not significant between patients undergoing iliac angioplasty and stenting
(IAS) with concomitant infrainguinal arterial reconstruction (CIAR) compared with those undergoing IAS alone
(Kaplan-Meier method, log-rank test, P  .81).
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Cumulative primary graft patency rate for all CIAR
was 81%, 52%, and 46% at 1, 3, and 5 years, respectively.
Univariate and regression analysis did not identify
independent predictors for primary graft failure after
CIAR.
For all patients, limb salvage rate at 1, 3, and 5 years was
99%, 91%, and 88%, respectively. Univariate survival analy-
sis revealed a trend for improved limb salvage in patients
undergoing IAS with CIAR, compared with patients un-
dergoing IAS alone (K-M, log rank test, P .07). Overall,
long-term survival was 92% at 1 year, 87% at 3 years, and
78% at 5 years.
DISCUSSION
The results of our study indicate that CIAR does not
improve iliac stent patency in patients undergoing IAS
to treat iliac lesions associated with significant infra-
inguinal arterial disease. Inasmuch as several observa-
tional studies,1,2 including our own experience,5 have
established that poor runoff is an independent predictor
for adverse outcome after IAS, our findings provide a
helpful guide in determining need for and efficacy of
CIAR in patients undergoing IAS who also have signifi-
cant infrainguinal disease. To determine which patients
would benefit from IAS with CIAR, stratified analyses
according to grade of ischemia were included in this
study. Although the severity of ischemia was not
significantly different between patients undergoing IAS
with CIAR and IAS alone, CIAR was performed more
frequently in patients with limb-threatening ischemia,
which suggests that critical ischemia was an important
factor in the decision to perform CIAR. Nonetheless,
38% of patients with disabling claudication also under-
went IAS with CIAR. Stratified analysis to investigate
the influence of CIAR on outcome of IAS in patients
with limb-threatening ischemia was limited in this series,
because of the small sample size in this subgroup of
patients. However, there was a trend for higher iliac
stent patency and improved limb salvage after IAS with
CIAR, compared with IAS alone. This trend was not seen
in patients with claudication. Thus infrainguinal arterial
reconstruction may be necessary only if there is no
clinical improvement in patients with disabling claudi-
cation after IAS, and probably in those with critical
ischemia.
A possible type II statistical error was considered in
the data analysis, because of the small sample size. A post
hoc power analysis was obtained to assess the beta error,
and was based on our previous publication.5 In the
previous study, poor runoff was associated with a three-
fold increased risk for primary iliac stent failure (RR, 3.1;
95% CI, 1.8-5.5). CIAR would be effective only if such
risk could be reduced. Sample size calculation revealed
that the data set was large enough to obtain 80% power,
with a two-sided P value of .05, to detect lack of benefit
of CIAR on the outcome of IAS; that is, adverse effects of
poor runoff on iliac stent patency could not be improved
with CIAR.
In a previous study18 we demonstrated that poor
infrainguinal runoff is the main risk factor for decreased
primary patency after both IAS and aortoiliac surgical
reconstruction in patients with moderately severe iliac
occlusive disease, that is, TASC type B and C iliac lesions.
Although inadequate runoff affects all types of inflow
procedures, outcome was significantly better in patients
undergoing aortoiliac surgical reconstruction compared
with those undergoing iliac artery angioplasty and stent-
ing. Because CIAR does not improve outcome of IAS in
patients with poor runoff, aortoiliac surgical reconstruc-
tion still offers the best long-term results in this sub-
group of patients.
There are several potential limitations to our study.
First, ours is a retrospective observational study, with
the potential bias and confounding effects inherent in all
observational studies. Second, although we included
patients from two busy institutions with ample experi-
ence in both endovascular and peripheral reconstruc-
tion, the number of patients was small and prevented
further stratified analysis free from type II statistical
error. Although only a randomized clinical trial could
assess the exact influence of concomitant infrainguinal
arterial reconstruction in patients undergoing iliac
artery angioplasty and stenting to treat iliac occlusive
disease with inadequate infrainguinal runoff, such trial
has not been performed and is unlikely to be conducted
in the future. Consequently, we must rely on data from
observational studies to draw conclusions and make
recommendations. The information obtained in this
study may therefore be useful to vascular surgeons, to
determine need for iliac artery angioplasty and stenting
with concomitant infrainguinal arterial reconstruction.
Inasmuch as many vascular surgeons have adopted
the strategy of concomitant procedures, considering
this approach more cost-effective and convenient for
patients, the present study indicates that concomitant
infrainguinal arterial reconstruction is not always
justified.
Although other methods of improving infrainguinal
outflow in patients with poor runoff, such as superior
femoral artery angioplasty or stenting and subintimal
angioplasty of crural vessels, were not assessed in this
study, these procedures would probably not offer addi-
tional benefit in terms of primary iliac stent patency,
compared with CIAR. However, these procedures are an
attractive alternative to CIAR, because they are less
invasive and outcome seems to be improving with expe-
rience.19,20
In conclusion, our data suggest that CIAR does not
improve iliac stent patency in patients undergoing IAS in
whom iliac lesions are associated with poor distal runoff.
Infrainguinal bypass procedures should therefore be re-
served for patients in whom clinical improvement is not
noted after IAS and possibly for those with limb-threat-
ening ischemia.
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DISCUSSION
Dr Eugene M. Langan III, MD (Greenville, SC). The group
from the University of Tennessee–Knoxville, now in concert with
the Montefiore group again, present their data on iliac artery
angioplasty and/or stenting. As this is the third consecutive year a
variant of this data is presented at this meeting, they have won a
virtual trifecta on iliac artery stenting.
This year they added to last year’s report and become
more specific to assess the effects of concomitant infrainguinal
reconstruction on iliac stent patency. Of the 394 iliac artery
stent procedures performed over a 52-year experience, 68, or
17%, in 62 patients were associated with poor distal runoff.
Distal revascularization was done in 31 patients, 25 or 81%, at
the same operative setting. Concerning to me is that 12 pa-
tients, or 44% of the combined group, underwent concomitant
lower extremity vascularization and iliac stenting for claudi-
cation. I would suggest that this is possibly overaggressive
therapy and that these patients may have significant im-
provement in ambulatory status without the added, more inva-
sive therapy. This also could be part of the reason that Dr
Timaran and his colleagues have found that distal revasculari-
zation at the same setting as iliac artery stenting may not always
be justified.
This paper also brings out a trend that is not highlighted
but is extremely important. There was a trend for improved limb
salvage with the combined procedures. This makes intuitive
sense. In our program, lower extremity revascularization is not
performed to assist in iliac artery endovascular intervention, but
to improve distal lower extremity perfusion. This seems to fit the
authors’ conclusion.
A point of interest and evolution in this group’s work is that
in this study all procedures were performed by vascular sur-
geons. In the original paper only 2 years ago, interventional
radiologists did the majority of the iliac interventions. This is a
change I applaud.
I have a few questions for Dr Timaran. Carlos, you state in
the manuscript that all revisions or occlusions were considered
a stent failure. I am unclear if this is a bypass graft revision
or a more proximal stent revision. If it is the bypass graft,
should this affect stent patency? Could you please comment on
this?
Next, in your previous studies renal failure was a marker for
iliac stenting failure. It makes sense that this would hold true for
patients requiring distal bypass. What is your opinion on the
change?
Last, we feel that there is great value to the profunda
femoral runoff, and at times will add profundaplasty to assist our
distal perfusion. Did your study point to any value of profunda-
plasty?
Dr Carlos H. Timaran. Regarding your first question, we
did try to separate primary iliac stent patency from the graft
patency of the infrainguinal arterial reconstructions. In most
cases, this was possible. We also used an extended
Cox regression model that allowed us to include time-depen-
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